Drug Approval | June 12, 2025
Zydus receives EIR for the API manufacturing facility at Ankleshwar and Dabhasa
Zydus receives EIR for the API manufacturing facility at Ankleshwar
Zydus receives EIR for the API manufacturing facility at Ankleshwar
This outcome reflects Innoxel Lifesciences' ongoing commitment to maintaining the highest standards of quality, compliance, and regulatory excellence
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
USFDA inspection at Alembic Pharma's Bioequivalence facility
The company will take all necessary steps to work with USFDA towards earliest remediation of the above facility
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
The institution will be spread over an area of more than 8 acres
ANVISA issues CGMP to Concord Biotech’s Unit I
BHL will undertake the development and supply of these molecules
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
